The processes of intraepithelial migration, intraluminal seeding, and field cancerization as models for initiation, spread, and recurrences of urothelial cell carcinoma (UCC) are reviewed in light of recent molecular investigations. The accumulated molecular data on synchronous and metachronous tumors indicate that the majority of recurrent and multiple tumors are monoclonal. Molecular data has also shown the presence of chromosomal and genetic changes in precursor lesions as well as in normal urothelial cells. Genetic-histological mapping of cystectomized bladders has shown that overt tumors occur as local events in areas of genetically altered urothelium. A model is put forward in which the tumor process is initiated by genetically altere...
BACKGROUND: Urothelial carcinomas originate from the epithelial cells of the inner lining of the bla...
Purpose: UC is a disease of the entire urothelium, characterized by multiplicity and multifocality. ...
AbstractManagement of unresectable urothelial cancer (UC) has been a clinical challenge for decades....
Tumor recurrence is a major clinical concern for patients with urothelial carcinoma of the urinary b...
Synchronous and metachronous tumors are frequently observed in the urinary tract and may be explaine...
Bladder cancer is characterized by high rates of recurrence and multifocality, features which have c...
Multifocality and recurrence of urothelial carcinoma may result from either the field effect of carc...
We used the fact that patients with non-muscle invasive bladder tumors show local recurrences and mu...
Purpose: To identify the origin of synchronous and metachronous urothelial carcinoma (UC) of the bla...
Bladder cancer is characterized by high rates of recurrence and multifocality, features which have c...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
Molecular changes occurring during invasion and clinical progression of cancer are difficult to stud...
<p>Molecular and kinetic analyses have contributed to our understanding of the biology of transition...
Urinary bladder cancer is the 11th most common cancer when considering both sexes together and the 7...
PURPOSE: UC is a disease of the entire urothelium, characterized by multiplicity and multifocality. ...
BACKGROUND: Urothelial carcinomas originate from the epithelial cells of the inner lining of the bla...
Purpose: UC is a disease of the entire urothelium, characterized by multiplicity and multifocality. ...
AbstractManagement of unresectable urothelial cancer (UC) has been a clinical challenge for decades....
Tumor recurrence is a major clinical concern for patients with urothelial carcinoma of the urinary b...
Synchronous and metachronous tumors are frequently observed in the urinary tract and may be explaine...
Bladder cancer is characterized by high rates of recurrence and multifocality, features which have c...
Multifocality and recurrence of urothelial carcinoma may result from either the field effect of carc...
We used the fact that patients with non-muscle invasive bladder tumors show local recurrences and mu...
Purpose: To identify the origin of synchronous and metachronous urothelial carcinoma (UC) of the bla...
Bladder cancer is characterized by high rates of recurrence and multifocality, features which have c...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
Molecular changes occurring during invasion and clinical progression of cancer are difficult to stud...
<p>Molecular and kinetic analyses have contributed to our understanding of the biology of transition...
Urinary bladder cancer is the 11th most common cancer when considering both sexes together and the 7...
PURPOSE: UC is a disease of the entire urothelium, characterized by multiplicity and multifocality. ...
BACKGROUND: Urothelial carcinomas originate from the epithelial cells of the inner lining of the bla...
Purpose: UC is a disease of the entire urothelium, characterized by multiplicity and multifocality. ...
AbstractManagement of unresectable urothelial cancer (UC) has been a clinical challenge for decades....